Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease

Norman E. Lepor; Stacey B. Gross; William L. Daley; Bruce A. Samuels; Michael J. Rizzo; Sean P. Luko; Ann Hickey; Neil A. Buchbinder; Tasneem Z. Naqvi

doi:10.1016/S0002-9149(00)00840-7

Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease

Norman E. Lepor, Stacey B. Gross, William L. Daley, Bruce A. Samuels, Michael J. Rizzo, Sean P. Luko, Ann Hickey, Neil A. Buchbinder, Tasneem Z. Naqvi

Cardiovascular Diseases

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Original language	English (US)
Pages (from-to)	107-110
Number of pages	4
Journal	American Journal of Cardiology
Volume	86
Issue number	1
DOIs	https://doi.org/10.1016/S0002-9149(00)00840-7
State	Published - Jul 1 2000

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/S0002-9149(00)00840-7

Cite this

@article{35e7c8393064493aaed6a5d31d55b1bd,

title = "Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease",

author = "Lepor, {Norman E.} and Gross, {Stacey B.} and Daley, {William L.} and Samuels, {Bruce A.} and Rizzo, {Michael J.} and Luko, {Sean P.} and Ann Hickey and Buchbinder, {Neil A.} and Naqvi, {Tasneem Z.}",

year = "2000",

month = jul,

day = "1",

doi = "10.1016/S0002-9149(00)00840-7",

language = "English (US)",

volume = "86",

pages = "107--110",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease

AU - Lepor, Norman E.

AU - Gross, Stacey B.

AU - Daley, William L.

AU - Samuels, Bruce A.

AU - Rizzo, Michael J.

AU - Luko, Sean P.

AU - Hickey, Ann

AU - Buchbinder, Neil A.

AU - Naqvi, Tasneem Z.

PY - 2000/7/1

Y1 - 2000/7/1

UR - http://www.scopus.com/inward/record.url?scp=0034237285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034237285&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(00)00840-7

DO - 10.1016/S0002-9149(00)00840-7

M3 - Article

C2 - 10867106

AN - SCOPUS:0034237285

SN - 0002-9149

VL - 86

SP - 107

EP - 110

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 1

ER -

Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this